Improved vaccine against PRRSV: Current Progress and future perspective

176Citations
Citations of this article
162Readers
Mendeley users who have this article in their library.

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV), one of the most economically significant pathogens worldwide, has caused numerous outbreaks during the past 30 years. PRRSV infection causes reproductive failure in sows and respiratory disease in growing and finishing pigs, leading to huge economic losses for the swine industry. This impact has become even more significant with the recent emergence of highly pathogenic PRRSV strains from China, further exacerbating global food security. Since new PRRSV variants are constantly emerging from outbreaks, current strategies for controlling PRRSV have been largely inadequate, even though our understanding of PRRSV virology, evolution and host immune response has been rapidly expanding. Meanwhile, practical experience has revealed numerous safety and efficacy concerns for currently licensed vaccines, such as shedding of modified live virus (MLV), reversion to virulence, recombination between field strains and MLV and failure to elicit protective immunity against heterogeneous virus. Therefore, an effective vaccine against PRRSV infection is urgently needed. Here, we systematically review recent advances in PRRSV vaccine development. Antigenic variations resulting from PRRSV evolution, identification of neutralizing epitopes for heterogeneous isolates, broad neutralizing antibodies against PRRSV, chimeric virus generated by reverse genetics, and novel PRRSV strains with interferon-inducing phenotype will be discussed in detail. Moreover, techniques that could potentially transform current MLV vaccines into a superior vaccine will receive special emphasis, as will new insights for future PRRSV vaccine development. Ultimately, improved PRRSV vaccines may overcome the disadvantages of current vaccines and minimize the PRRS impact to the swine industry.

Figures

  • TABLE 1 | List cellular receptors of PRRSV and their functions during PRRSV infection.
  • TABLE 2 | List of PRRSV vaccine or vaccine under development.
  • TABLE 3 | List of PRRSV-ORFs, corresponding viral proteins and potential for virus neutralization.

References Powered by Scopus

IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

1386Citations
N/AReaders
Get full text

Viruses and interferon: A fight for supremacy

1054Citations
N/AReaders
Get full text

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

990Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Key gaps in the knowledge of the porcine respiratory reproductive syndrome virus (PRRSV)

115Citations
N/AReaders
Get full text

Interplay between Janus kinase/signal transducer and activator of transcription signaling activated by type I interferons and viral antagonism

114Citations
N/AReaders
Get full text

Commercial prrs modified‐live virus vaccines

68Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nan, Y., Wu, C., Gu, G., Sun, W., Zhang, Y. J., & Zhou, E. M. (2017, August 28). Improved vaccine against PRRSV: Current Progress and future perspective. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2017.01635

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘24‘25010203040

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 57

73%

Researcher 16

21%

Professor / Associate Prof. 4

5%

Lecturer / Post doc 1

1%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 31

32%

Veterinary Science and Veterinary Medic... 30

31%

Biochemistry, Genetics and Molecular Bi... 20

21%

Immunology and Microbiology 16

16%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0